Delamanid
Deltyba (delamanid) is a small molecule pharmaceutical. Delamanid was first approved as Deltyba on 2014-04-27. It has been approved in Europe to treat multidrug-resistant tuberculosis.
| Trade Name | Deltyba |
|---|---|
| Common Name | Delamanid |
| Indication | multidrug-resistant tuberculosis |
| Drug Class | Mycolic acid inhibitors |
